BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23141635)

  • 1. [Trisomy 21 and cancers].
    Ayed W; Gouas L; Penault-Llorca F; Amouri A; Tchirkov A; Vago P
    Morphologie; 2012 Oct; 96(314-315):57-66. PubMed ID: 23141635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of malignant disorders in individuals with Down's syndrome.
    Hasle H
    Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor profile in Down syndrome.
    Satgé D; Sommelet D; Geneix A; Nishi M; Malet P; Vekemans M
    Am J Med Genet; 1998 Jul; 78(3):207-16. PubMed ID: 9677053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of leukaemia and solid tumours in individuals with Down's syndrome.
    Hasle H; Clemmensen IH; Mikkelsen M
    Lancet; 2000 Jan; 355(9199):165-9. PubMed ID: 10675114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occurrence of cancer in individuals with Down syndrome].
    Hasle H; Clemmensen IH; Mikkelsen M
    Ugeskr Laeger; 2000 Aug; 162(34):4535-9. PubMed ID: 10981221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of cancer in individuals with Down syndrome].
    Hasle H; Clemmensen IH; Mikkelsen M
    Tidsskr Nor Laegeforen; 2000 Oct; 120(24):2878-81. PubMed ID: 11143409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast cancer in women with trisomy 21].
    Satgé D; Sasco AJ; Pujol H; Rethoré MO
    Bull Acad Natl Med; 2001; 185(7):1239-52; discussion 1252-4. PubMed ID: 11975321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature.
    Satgé D; Sasco AJ; Curé H; Leduc B; Sommelet D; Vekemans MJ
    Cancer; 1997 Sep; 80(5):929-35. PubMed ID: 9307193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiency in Down's syndrome: low levels of serum thymic factor in trisomic children.
    Duse M; Brugo MA; Martini A; Tassi C; Ferrario C; Ugazio AG
    Thymus; 1980 Dec; 2(3):127-31. PubMed ID: 6451065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome: paradox of a tumour repressor.
    Threadgill DW
    Nature; 2008 Jan; 451(7174):21-2. PubMed ID: 18172483
    [No Abstract]   [Full Text] [Related]  

  • 11. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
    Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenesis in Down's syndrome: big lessons from a small chromosome.
    Nižetić D; Groet J
    Nat Rev Cancer; 2012 Oct; 12(10):721-32. PubMed ID: 22996602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.
    DeYoung MP; Tress M; Narayanan R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4760-5. PubMed ID: 12676991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
    Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
    Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenesis in Down syndrome: what can be learned from trisomy 21?
    Satgé D; Bénard J
    Semin Cancer Biol; 2008 Oct; 18(5):365-71. PubMed ID: 18455928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma.
    Satgé D; Monteil P; Sasco AJ; Vital A; Ohgaki H; Geneix A; Malet P; Vekemans M; Réthoré MO
    Cancer; 2001 Apr; 91(8):1458-66. PubMed ID: 11301393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chromosome 21 in hematology and oncology.
    Fonatsch C
    Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ cell migration and early development of the gonads in the trisomy 16 mouse--an animal model for Down's syndrome.
    Leffler A; Ludwig M; Schmitt O; Busch LC
    Ann Anat; 1999 May; 181(3):247-52. PubMed ID: 10363106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.